Sign Up
Stories
Biotech Funding Challenges and IPO Drought
Share
Biotech Downturn and Funding Challenges
International Stocks Rise, Thermo Fisher...
AHF Criticizes Gilead Sciences for Profi...
AbbVie's Healthcare Acquisitions
Afya Limited Expands Medical Seats in Br...
Overview
API
Biotech industry faces funding challenges, IPO drought, and a funding squeeze, impacting companies like BioNTech, Thermo Fisher, and IPOs from Lexeo Therapeutics and Abivax.
Ask a question
How might the funding challenges and IPO drought affect the long-term growth and innovation in the biotech industry?
In what ways do the shifting focus in the biotech industry reflect broader trends in healthcare and medical research?
What strategies can biotech companies adopt to navigate the current funding challenges and IPO drought?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jul 2023
Aug 2023
Sep 2023
Oct 2023
Nov 2023
Coverage